Further studies are needed to evaluate the therapeutic potential of MR blockers even as anti-inflammatory drugs, especially in some gynecological diseases characterized by a pro-inflammatory state and associated with hypertension and an increased cardio-metabolic risk, that could be related to Aldo dysregulation. The gene discussed is NR3C2; the disease is Hypertension.